Indian pharma's global R&D surge: companies eye US and Europe for innovationby The Uttam Hindu 25 Dec 2024 2:00 PM IST
Failure of AstraZeneca’s opioid drug trial a major blow for addiction medications: Reportby Deepak 27 Nov 2024 4:06 PM IST
